The next wave of wearable exoskeletons for mobility support

Wearable exoskeletons have spent years inside rehabilitation laboratories, helping a limited number of users take assisted steps. The next wave is aimed at a much broader role: devices that support a person through a workday, across a school campus, or between home and public transport. The shift requires better batteries, lighter materials and assistance that responds to the wearer rather than following a fixed robotic pattern.

Australia offers a demanding test. Its ageing population and dispersed communities create substantial mobility needs, while extreme heat, footpath gaps and distance make heavy equipment impractical. The relevant standard is no longer a convincing laboratory walk. It is safe, reliable help that fits ordinary routines, public spaces and an Australian funding system.

From clinical recovery to daily movement

Clinical systems still dominate, especially for spinal cord injury, stroke, cerebral palsy and multiple sclerosis. Powered rigs can guide the hips and knees, while passive braces and soft exosuits add spring or motor assistance without the theatre of a full metal frame. That distinction matters because the most useful device may be the one a person forgets they are wearing.

Newer systems combine joint-angle sensors, pressure-sensitive footwear and force measurements to recognise a wearer’s movement in real time. Artificial intelligence can learn each person’s gait and adjust assistance at the next step. The strongest systems will let clinicians set boundaries, show why assistance changed and return to manual or passive mode when confidence drops.

Australian users may value different outcomes in different places. A commuter in Melbourne may need help boarding a tram and climbing a station stair, while a cane user in outer Sydney may value stability on a long, sloping footpath. A device useful for one journey can be irrelevant for another.

Lighter hardware and more responsive control

Hardware is shedding bulk through textiles, compact actuators and lighter batteries. Heat management is crucial in Australia: a motor that overheats during a humid summer commute will fail at exactly the moment it is needed. Engineers are also designing joints that can bypass resistance rather than forcing every movement through a motor.

Sensor fusion will make these products more responsive, but it also expands the attack surface. Camera-based tele-rehabilitation can be spoofed, and clinical decisions based on altered movement data could be unsafe. Methods described in real-time deepfake detection point toward a broader need for continuous authentication, with wearable data checked against secure device records.

Safety must remain visible and physical. A wearer needs an immediate stop control, clear limits on how much torque the machine can add, and a mechanical path that does not trap the body if power fails. Independent testing should include uneven pavements, crowded trains, ramps and wet grass rather than a flat hospital corridor.

Regulation, funding and the Australian market

Regulation begins with intended use. In Australia, a system sold to treat, rehabilitate or compensate for injury is generally a medical device regulated by the Therapeutic Goods Administration. Sponsors need evidence covering safety, performance, software controls and post-market monitoring. Privacy law also applies when a service handles identifiable health information, while disability and transport legislation shapes public accessibility.

Funding is fragmented. The National Disability Insurance Scheme may support eligible assistive technology, but powered exoskeletons usually require individual evidence and plan justification; Medicare rebates generally do not cover consumer purchases. Workers’ compensation, insurers, aged-care operators and employers can become buyers when the link between mobility and daily participation is demonstrated.

The local market is therefore likely to start with rehabilitation hospitals, specialist clinics, trial networks and selected employers rather than mass retail. Hospitals in Melbourne, Sydney, Brisbane and Perth can compare systems under shared protocols, while regional trials could test whether support survives long travel and limited local repair services. Standardised outcome data would make those comparisons more useful.

Designing for everyday Australian conditions

Routine design matters more than laboratory performance. Australian cities contain both accessible rail corridors and hundreds of older suburban bus routes, footpaths that shift after rain, and steep entries that no sensor map can fully describe. Exoskeletons intended for public use must cope with kerbs, tactile paving, crowded platforms and the short, awkward gaps involved in getting on and off vehicles.

Remote support will expand, but visual records need context. A short video cannot show whether a joint is loaded correctly, and synthetic media can imitate a demonstration. Practical advice on AI-generated fake videos helps explain why families and clinicians should treat uploaded footage as supporting evidence, alongside device logs and live checks, rather than proof by itself.

Family coordination may happen in familiar messaging groups. Care teams should not ask patients to use unofficial WhatsApp tools for therapy data, because modified clients may weaken account security and expose sensitive conversations. A hospital-run portal with accessible updates, consent controls and direct technical support is a safer foundation.

A measured path to wider access

Evidence should centre on participation. Trials need to track falls, transfers, fatigue, skin pressure, device abandonment and time spent in paid or social activity, not only gait speed. Wearers should also report whether a device feels stable, whether its weight is acceptable and whether assistance feels predictable on a real street.

Procurement can accelerate progress through pooled purchasing, shared training and service plans. Hospitals, aged-care providers and transport agencies could require interoperable charging, repair and data standards, while disability advocates should be involved before public trials begin. The goal is a service around the device, since hardware without maintenance will widen access gaps.

A concrete next step is for an Australian rehabilitation network to run a twelve-month pilot across Melbourne, Sydney and a regional centre, measuring daily mobility, falls, energy use and user experience, then publish the results before seeking public funding for wider access.